K. Ballen

M. Aljurf, R. Gale, K. Ballen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.

D. Porter, K. Ballen, D. Confer, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant.

K. Ballen, O. Ringdén, D. Rizzieri, 2020, Biology of Blood and Marrow Transplantation.

Matching at HLA-C improved the outcomes after double umbilical cord blood transplantation for recipients of 2–4/6 HLA-matched grafts

J. Wagner, K. Ballen, R. Soiffer, 2017 .

Update on umbilical cord blood transplantation

K. Ballen, 2017, F1000Research.

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR

S. Montoto, Sonali M. Smith, D. Maloney, 2014, Bone Marrow Transplantation.

Double Umbilical Cord Blood Transplantation in Adults

K. Ballen, 2009 .

Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT

S. Saidman, D. Ting, A. Muzikansky, 2008, Bone Marrow Transplantation.

Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen

S. Saidman, D. Ting, N. Tarbell, 2007, Bone Marrow Transplantation.

Cellular immune therapy for refractory cancers: novel therapeutic strategies.

P. Westervelt, D. Porter, P. Quesenberry, 2005, Experimental hematology.

Low Dose Total Body Irradiation Followed by Allogeneic Lymphocyte Infusion for Refractory Hematologic Malignancy—an Updated Review

D. Porter, P. Quesenberry, K. Ballen, 2004, Leukemia & lymphoma.

The Humanized Anti PD-1 Antibody, CT-011, Increases Specific CD4+ Effector/Memory and Memory T Lymphocytes in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Following Autologous Stem Cell Transplantation (AuSCT).

L. Gordon, J. Winter, J. Fay, 2009 .

A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia

D. Neuberg, T. Graubert, K. Ballen, 2019, Cancer.

Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma

B. Yeap, K. Ballen, T. Spitzer, 2009, Bone Marrow Transplantation.

The great debate: haploidentical or cord blood transplant

K. Ballen, T. Spitzer, Thomas R. Spitzer, 2011, Bone Marrow Transplantation.

Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3‐ITD acute myeloid leukaemia in first complete remission

S. Nikiforow, K. Ballen, D. DeAngelo, 2016, British journal of haematology.

Phase I trial of parathyroid hormone to facilitate stem cell mobilization.

M. Konopleva, B. Yeap, E. Shpall, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

S. Solomon, D. Blaise, A. Nagler, 2019, Bone Marrow Transplantation.

Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!

K. Ballen, T. Kindwall‐Keller, 2017, The oncologist.

BMT CTN State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year.

E. Leifer, P. Hari, H. Heslop, 2021, Transplantation and cellular therapy.

[American Society of Blood and Marrow Transplantation (ASBMT) Committee Report: collection and preservation of cord blood for personal use].

K. Ballen, T. Lane, S. Stewart, 2008, Zhongguo shi yan xue ye xue za zhi.

Monoclonal antibody AG-1 initiates platelet activation by a pathway dependent on glycoprotein IIb-IIIa and extracellular calcium.

J. Miller, K. Ballen, M. Mendelsohn, 1992, Biochimica et biophysica acta.

Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.

S. Saidman, K. Ballen, F. Preffer, 2007, Experimental hematology.

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD AML

A. Lane, S. Verselis, K. Ballen, 2014 .

Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia.

A. Lane, S. Verselis, K. Ballen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cord blood transplant for acute myeloid leukaemia

K. Ballen, H. Lazarus, 2016, British journal of haematology.

Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non‐obese diabetic–severe combined immunodeficient assay

P. Quesenberry, K. Ballen, C. Hsieh, 2001, British journal of haematology.

Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD‐scid mice

J. Wuu, P. Quesenberry, K. Ballen, 2000, British journal of haematology.

Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant.

K. Ballen, Yi-Bin Chen, T. Spitzer, 2012, Blood.

BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation.

K. Ballen, V. Boussiotis, F. Marty, 2015, Transplant immunology.

Umbilical Cord Blood Transplantation

K. Ballen, M. Delaney, 2015, Journal of intensive care medicine.

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

M. Griesshammer, N. Kröger, T. Barbui, 2015, Leukemia.

A Phase II Study of Dasatinib in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL/SLL).

D. Zahrieh, K. Ballen, Jennifer R. Brown, 2007 .

Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.

H. Deeg, P. Hari, K. Ballen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

Alan M. Miller, M. Norkin, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of transplantation for myelofibrosis.

N. Kröger, M. Horowitz, R. Gale, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Safety and Cost of Hyperhydration for the Prevention of Hemorrhagic Cystitis in Bone Marrow Transplant Recipients

W. Levy, P. Quesenberry, K. Ballen, 1999, Oncology.

Umbilical cord blood: The promise and the uncertainty

K. Ballen, T. Kindwall‐Keller, 2020, Stem cells translational medicine.

Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis

J. Ritz, J. Brown, K. Stevenson, 2011, Bone Marrow Transplantation.

Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial.

Traci M. Blonquist, D. Neuberg, T. Graubert, 2019, The Lancet. Haematology.

J. Lacy, J. Henson, K. Ballen, 2006, Neuro-Oncology.

A multicenter, retrospective, case‐cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients

K. Ballen, D. Braun, D. Leffler, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Umbilical Cord Blood Transplantation: Challenges and Future Directions

K. Ballen, 2017, Stem cells translational medicine.

Cord Blood Transplants: Perinatal Stem Cells in Clinical Practice

K. Ballen, R. Haspel, 2010 .

B. Yeap, K. Ballen, R. Soiffer, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Current status of cord blood banking and transplantation in the United States and Europe.

J Wagner, J. Wagner, P. Rebulla, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Current Status of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation in AML Management 9

E. Shpall, A. Barrett, K. Ballen, 2010 .

Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

D. Neuberg, K. Ballen, D. DeAngelo, 2012, Leukemia research.

Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation

Traci M. Blonquist, D. Neuberg, K. Ballen, 2018, Cancer.

A unique PML-RARα rearrangement involving chromosomes 11, 15, and 17 in a patient with acute promyelocytic leukemia.

P. D. Dal Cin, N. Lindeman, K. Ballen, 2013, Experimental Hematology.

Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemia

K. Ballen, A. Fathi, G. Hobbs, 2018, Leukemia & lymphoma.

Treatment of acute leukaemia in adult Jehovah's Witnesses

K. Ballen, F. El Chaer, 2019, British journal of haematology.

Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations.

D. Neuberg, K. Ballen, D. DeAngelo, 2011, Leukemia research.

Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia

B. Leber, D. Neuberg, S. Sallan, 2014, Leukemia.

The expanding frontier of hematopoietic cell transplantation

K. Ballen, Yi-Bin Chen, T. Spitzer, 2012, Cytometry. Part B, Clinical cytometry.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-2004. A 31-year-old man with bilateral testicular enlargement.

K. Ballen, R. Hasserjian, 2004, The New England journal of medicine.

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

J. Wingard, K. Ballen, Y. Nieto, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

How to manage the transplant question in myelofibrosis

K. Ballen, 2012, Blood Cancer Journal.

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia

B. Ebert, K. Ballen, D. DeAngelo, 2018, American journal of hematology.

Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis

Traci M. Blonquist, D. Neuberg, K. Ballen, 2015, Leukemia & lymphoma.

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

E. Shpall, J. Wingard, K. Ballen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation

E. Shpall, J. Wingard, K. Ballen, 2012 .

Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.

J. Ritz, K. Ballen, T. Karantanos, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cardiac Transplantation Followed by Dose-Intensive Melphalan and Autologous Stem-Cell Transplantation for Light Chain Amyloidosis and Heart Failure

C. Newton-Cheh, M. Skinner, D. Seldin, 2010, Transplantation.

ORIGINAL ARTICLE Expression of a4b7 integrin on memory CD8 þ T cells at the presentation of acute intestinal GVHD

J. Ritz, K. Ballen, R. Soiffer, 2013 .

Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.

L. Zon, W. Goessling, C. Desponts, 2013, Blood.

Is there a best graft source of transplantation in acute myeloid leukemia?

K. Ballen, 2015, Best practice & research. Clinical haematology.

Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

J. Ritz, P. Armand, K. Ballen, 2011, Blood.

Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome

K. Ballen, Yi-Bin Chen, 2009, F1000 medicine reports.

New trends in umbilical cord blood transplantation.

K. Ballen, 2005, Blood.

Double cord blood transplants

K. Ballen, R. Haspel, 2006, Stem Cell Reviews.

Double cord blood transplants: filling a niche?

K. Ballen, R. Haspel, 2006, Stem cell reviews.

Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

K. Ballen, B. Bierer, H. Weinstein, 1994, Blood.

The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

D. Blaise, A. Nagler, M. Mohty, 2018, Bone Marrow Transplantation.

Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

A. LaCasce, D. Neuberg, P. Armand, 2011, Clinical Cancer Research.

Adhesion receptor expression by CD34+ cells from peripheral blood or bone marrow grafts: correlation with time to engraftment.

K. Ballen, H. Valinski, P. Becker, 2006, Experimental hematology.

Cord blood unit access and selection: 2010 and beyond: best practices and emerging trends in cord blood unit selection.

K. Ballen, M. Maiers, M. Boo, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide.

M. Horowitz, K. Ballen, C. Bredeson, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

J. Esteve, F. Baron, M. Labopin, 2019, Haematologica.

Expression of α4β7 integrin on memory CD8+ T cells at the presentation of acute intestinal GVHD

J. Ritz, K. Ballen, R. Soiffer, 2013, Bone Marrow Transplantation.

malignancy infusion may induce remission in patients with refractory hematologic Low-dose total body irradiation followed by allogeneic lymphocyte

W. Levy, F. Chiafari, P. Quesenberry, 2013 .

The role of HLA in umbilical cord blood transplantation.

K. Ballen, M. Delaney, 2010, Best practice & research. Clinical haematology.

Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.

K. Ballen, J. Antin, 1993, Hematology/oncology clinics of North America.

Expression and activation of protein kinase C isoforms in a human megakaryocytic cell line.

K. Ballen, B. Ewenstein, R. Handin, 1996, Experimental hematology.

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

J. Wingard, K. Ballen, Juan Wu, 2011, Blood.

The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.

K. Ballen, R. Hartzman, N. Kernan, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.

P. Hari, R. Kyle, Shaji K. Kumar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of twin and autologous transplants for multiple myeloma.

R. Fonseca, P. Hari, R. Kyle, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fatal Acute Respiratory Failure Following Vinblastine and Mitomycin Administration for Breast Cancer

K. Ballen, S. Weiss, KAREN K. BALLEN, 1988, American Journal of the Medical Sciences.

Has umbilical cord blood transplantation for AML become mainstream?

K. Ballen, J. Barker, 2013, Current opinion in hematology.

EFFECTS OF SPLEEN STATUS ON EARLY OUTCOMES AFTER HEMATOPOIETIC CELL TRANSPLANTATION

M. Pasquini, K. Ballen, U. Popat, 2012, Bone Marrow Transplantation.

Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years.

S. Nikiforow, P. Armand, K. Ballen, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN‐AML) and FLT3ITD

D. Neuberg, B. Wolpin, K. Ballen, 2011, American journal of hematology.

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with FLT3-ITD AML

S. Verselis, K. Ballen, R. Soiffer, 2014 .

Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.

K. Ballen, T. Anagnostou, Yi-Bin Chen, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous stem-cell transplantation can be performed safely without the use of blood-product support.

B. Yeap, K. Ballen, D. Henry, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Umbilical cord blood transplantation: the first 25 years and beyond.

K. Ballen, H. Broxmeyer, E. Gluckman, 2013, Blood.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Defining the intensity of conditioning regimens: working definitions.

B. Sandmaier, D. Blaise, M. Pasquini, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.

B. Sandmaier, M. Pasquini, M. Horowitz, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In utero or ex utero cord blood collection: which is better?

K. Ballen, T. Lane, L. Lasky, 2002, Transfusion.

Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

D. Blaise, A. Nagler, M. Mohty, 2018, Bone Marrow Transplantation.

M. Pasquini, K. Ballen, H. Lazarus, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis.

J. Ritz, K. Stevenson, P. Armand, 2010, Blood.

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.

J. Wagner, F. Appelbaum, K. Ballen, 2010, Blood.

Reduced-intensity conditioning and umbilical cord blood transplantation in adults

K. Ballen, C. Cutler, 2009, Bone Marrow Transplantation.

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

M. Krem, C. Hourigan, M. Aljurf, 2021, Blood advances.

Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia.

K. Ballen, R. Soiffer, Yi-Bin Chen, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.

P. Armand, K. Ballen, R. Soiffer, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks.

J. Kurtzberg, K. Ballen, T. Lane, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Donna Neuberg, Steven M Kornblau, Johannes Köster, 2016, Cancer cell.

MLL-Rearranged Acute Lymphoblastic Leukemia

K. Ballen, M. Keng, F. El Chaer, 2020, Current Hematologic Malignancy Reports.

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

P. Hari, R. Kyle, D. Reece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysis.

Traci M. Blonquist, D. Neuberg, K. Ballen, 2014, Leukemia research.

Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer.

Chung-Cheng Hsieh, Pagona Lagiou, D. Trichopoulos, 2005, Cancer research.

Stem Cells and Prenatal Origin of Breast Cancer

P. Quesenberry, K. Ballen, P. Lagiou, 2004, Cancer Causes & Control.

Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact

K. Ballen, T. Spitzer, M. Dowling, 2018, Bone Marrow Transplantation.

High‐resolution HLA matching in double‐umbilical‐cord‐blood reduced‐intensity transplantation in adults

B. Yeap, S. Saidman, K. Ballen, 2009, Transfusion.

Selection of the Optimal Cord Blood Unit

K. Ballen, 2014 .

Improving outcomes in umbilical cord blood transplantation: state of the art.

K. Ballen, C. Cutler, 2012, Blood reviews.

Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re‐induction chemotherapy

S. Carr, A. Letai, D. Neuberg, 2019, American journal of hematology.

Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells.

K. Ballen, D. Greiner, L. Shultz, 2003, Experimental hematology.

SCT in Jehovah's Witnesses: the bloodless transplant

K. Ballen, J. Sloan, 2008, Bone Marrow Transplantation.

Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia

D. Neuberg, J. Kolitz, K. Stevenson, 2016, Cancer.

Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

P. Armand, K. Ballen, R. Soiffer, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.

M. Meyerson, D. Gevers, F. Duke, 2013, The New England journal of medicine.

Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.

J. Klein, D. Friedman, K. Ballen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

M. Pasquini, K. Ballen, H. Khoury, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes and management strategies for graft failure after umbilical cord blood transplantation

S. Nikiforow, K. Ballen, R. Soiffer, 2014, American journal of hematology.

Is anemia a harbinger of poorer outcomes after allogeneic hematopoietic cell transplant?

K. Ballen, T. Kindwall‐Keller, 2019, Bone Marrow Transplantation.

Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease

E. Guinan, K. Ballen, B. Bierer, 1994 .

Association of graft-versus-host-disease with neurologic complications: clinical paradigm and future directions

K. Ballen, A. Im, S. Hashmi, 2021, Bone Marrow Transplantation.

Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

J. Wagner, J. Kurtzberg, E. Shpall, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipients.

J. Ritz, S. Nikiforow, E. Shpall, 2017, Cytotherapy.

Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.

J. Kurtzberg, A. Nagler, E. Shpall, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.

J. Ritz, K. Stevenson, P. Armand, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Introduction to Cord Blood Special Issue

K. Ballen, 2009, Bone Marrow Transplantation.

Unlicensed umbilical cord blood units provide a safe and effective graft source for a diverse population: A study of 2456 umbilical cord blood recipients.

J. Kurtzberg, E. Shpall, K. Ballen, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood donation: public or private?

J. Kurtzberg, K. Ballen, F. Verter, 2015, Bone Marrow Transplantation.

Excellent Outcomes in 1589 Patients Receiving Umbilical Cord Blood Transplantation Using Unlicensed Units From a Centralized Cord Blood Registry

J. Kurtzberg, E. Shpall, K. Ballen, 2017 .

Donor-derived second hematologic malignancies after cord blood transplantation.

B. Yeap, K. Ballen, R. Soiffer, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning

J. Wagner, K. Ballen, M. Verneris, 2021, Blood advances.

Blockade of IL-15 Utilizing Bnz-1, a Selective γ-Chain Inhibiting Peptide, Is Safe and Has Clinical Activity in Patients with T-Cell Large Granular Lymphocytic Leukemia (T-LGLL): Results of a Phase I/II Multi-Center Clinical Trial

T. Waldmann, K. Ballen, K. Rogers, 2019, Blood.

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

W. Wood, M. Sorror, F. Baron, 2017, Blood.

Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes.

J. Klein, J. Kurtzberg, J. Wingard, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Advances in umbilical cord blood transplantation.

K. Ballen, 2006, Current stem cell research & therapy.

Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.

J. Ritz, P. Armand, K. Ballen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation

J. Ritz, S. Nikiforow, P. Armand, 2019, Bone Marrow Transplantation.

ATG for cord blood transplant: yes or no?

K. Ballen, 2014, Blood.

IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in Adults

J. Ritz, S. Nikiforow, K. Ballen, 2015, PloS one.

Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults

K. Ballen, Yi-Bin Chen, T. Spitzer, 2014, American journal of hematology.

A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients

E. Gehan, C. Isaacs, D. Hayes, 2005, Breast Cancer Research and Treatment.

Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts.

J. Wagner, K. Ballen, R. Soiffer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor-speciﬁc anti-HLA antibodies predict outcome in double umbilical cord blood transplantation

J. Ritz, P. Armand, K. Ballen, 2011 .

A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial

D. Neuberg, S. Sallan, L. Silverman, 2015 .

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

B. Yeap, K. Ballen, R. Soiffer, 2005 .

Myelofibrosis: let’s go high!

K. Ballen, 2021, Bone Marrow Transplantation.

Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.

Maria E. Kempner, P. Oefner, Y. Taur, 2018, Blood advances.

P. Bierman, E. Montserrat, K. Ballen, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of Bone Marrow Transplantation for Myelofibrosis.

M. Horowitz, K. Ballen, K. Sobocinski, 2005 .

Dasatinib Has Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL/SLL), a Phase II Trial

D. Neuberg, K. Ballen, Jennifer R. Brown, 2008 .

Stem Cell Engraftment Strategies

P. Quesenberry, M. Dooner, K. Ballen, 2001, Annals of the New York Academy of Sciences.

Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia

D. Neuberg, D. Zahrieh, K. Ballen, 2008, Clinical Cancer Research.

Acute lymphoblastic leukemia, version 2.2015: Clinical practice guidelines in oncology

Patrick W. Burke, Andrew D. Zelenetz, Patricia Aoun, 2015 .

Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host disease.

K. Ballen, Yi-Bin Chen, A. El-Jawahri, 2017, Blood advances.

Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries

Ibrahim N. Muhsen, W. Wood, M. Aljurf, 2019, Bone Marrow Transplantation.

Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.

W. Wood, M. Aljurf, K. Ballen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia

K. Ballen, Indumathy Varadarajan, 2022, Frontiers in Oncology.

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

M. Norkin, M. Boeckh, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation

B. Yeap, K. Ballen, R. Soiffer, 2008, Bone Marrow Transplantation.

Overview of Stem Cell Transplantation for Lymphoma

K. Ballen, 2013 .

Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.

P. Hammerman, K. Ballen, Yi-Bin Chen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Isocitrate dehydrogenase 1 and 2 mutations, 2‐hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia

A. Iafrate, D. Neuberg, Hua Yang, 2018, Cancer.

Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.

D. Heitjan, P. Hari, R. Kyle, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

A. LaCasce, D. Neuberg, P. Armand, 2011 .

Cancer Therapy : Clinical Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

A. LaCasce, D. Neuberg, P. Armand, 2011 .

Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and increase of T regulatory cells.

J. Ritz, K. Ballen, T. Karantanos, 2019, Clinical immunology.

transplantation Prostaglandin-modulated umbilical cord blood hematopoietic stem cell

L. Zon, W. Goessling, C. Desponts, 2014 .

Cord colitis syndrome in cord-blood stem-cell transplantation.

A. Bellizzi, K. Ballen, R. Soiffer, 2011, New England Journal of Medicine.

Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies

A. Lane, J. Maciejewski, K. Ballen, 2013, Blood Cancer Journal.

Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.

B. Yeap, K. Ballen, F. Preffer, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research

J. Szer, M. Tallman, K. Ballen, 2013, Haematologica.

New trends in transplantation: the use of Thymoglobulin®

K. Ballen, 2009 .

Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation

L. Traeger, J. Temel, T. Graubert, 2015, Cancer.

Pediatric‐inspired therapy compared to allografting for Philadelphia chromosome‐negative adult ALL in first complete remission

D. Neuberg, S. Sallan, J. Bergeron, 2016, American journal of hematology.

High Rate of Second Malignancies after Reduced Intensity Double Cord Blood Transplants in Adults.

B. Yeap, K. Ballen, R. Soiffer, 2008 .

When to Refer a Patient for CAR T-Cell Therapy

K. Ballen, C. Portell, V. Orellana-Noia, 2020 .

transplantation in adults depends on reconstitution of thymopoiesis Clearance of CMV viremia and survival after double umbilical cord blood

J. Ritz, K. Stevenson, P. Armand, 2013 .

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.

H. Goldschmidt, P. Hari, D. Reece, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase II Study of Parathyroid Hormone following Sequential Unrelated Cord Blood Transplantation

E. Shpall, K. Ballen, D. Avigan, 2008 .

Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program.

N. Kröger, M. Perales, M. Mohty, 2021, Transplantation and cellular therapy.

Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell transplantation: does it make a difference?

K. Ballen, F. El Chaer, 2022, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

H. Deeg, D. Porter, J. Cortes, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.

M. Pasquini, J. Wingard, K. Ballen, 2019, Blood advances.

Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.

W. Wood, M. Aljurf, K. Ballen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The optimal donor source for acute myeloid leukemia: do we know the answer?

K. Ballen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia

D. Neuberg, K. Ballen, A. Fathi, 2013, American journal of hematology.

Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia‐negative acute lymphoblastic leukemia in first remission

D. Neuberg, K. Ballen, R. Soiffer, 2016, American journal of hematology.

Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.

B. Sandmaier, D. Porter, K. Ballen, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.

M. Pasquini, K. Ballen, J. Liesveld, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prophylactic pretransplant ganciclovir to reduce cytomegalovirus infection after hematopoietic stem cell transplantation.

G. Petroni, K. Ballen, T. Kindwall‐Keller, 2021, Hematology/oncology and stem cell therapy.

K. Ballen, H. Lazarus, L. Isola, 2008 .

Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults

D. Neuberg, K. Stevenson, K. Ballen, 2022, Leukemia & lymphoma.

Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia.

M. Pasquini, K. Ballen, H. Lazarus, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

M. Pasquini, J. Wingard, K. Ballen, 2018, Blood.

Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation

L. Traeger, J. Temel, T. Graubert, 2014, Bone Marrow Transplantation.

The effect of smoking on allogeneic transplant outcomes.

K. Ballen, O. Ringdén, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Neuroendocrine carcinoma in a patient with hairy cell leukemia: a case report.

K. Ballen, A. Neish, M. Seiler, 1992, Medical and pediatric oncology.

Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations

D. Neuberg, K. Ballen, D. DeAngelo, 2010, American journal of hematology/oncology.

Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis.

G. Abel, L. Traeger, J. Temel, 2016, The Lancet. Haematology.

Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial

M. Mayes, K. Sullivan, D. Furst, 2013, The Journal of Rheumatology.

337: Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis

K. Ballen, R. Soiffer, T. Spitzer, 2007 .

Bone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survival

L. Kalish, L. Shulman, K. Ballen, 1994, Cancer.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-2005. A 39-year-old woman with headache, stiff neck, and photophobia.

K. Ballen, R. Hasserjian, 2005, The New England journal of medicine.

Use of 2HG Levels in the Serum, Urine, or Bone Marrow to Predict IDH Mutations in Adults with Acute Myeloid Leukemia

A. Iafrate, D. Neuberg, K. Ballen, 2015 .

Addition of Bortezomib (Velcade) to AML Induction Chemotherapy Is Well Tolerated and Results in a High Complete Remission Rate.

D. Neuberg, K. Ballen, I. Galinsky, 2005 .

Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT

J. Ritz, S. Nikiforow, K. Ballen, 2014, Blood Cancer Journal.

Acute lymphoblastic leukemia.

A. Zelenetz, M. Millenson, O. Frankfurt, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank

J. Kurtzberg, K. Ballen, T. Lane, 2006, Transfusion.

Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors

J. Wingard, K. Ballen, M. Popovsky, 2002, Transfusion.

Denials Of Treatment Coverage By Health Insurance Carriers Restrict Patient Recruitment On A Randomized Clinical Trial: Experience Of 95 Patients With Systemic Sclerosis (SSc) Enrolled In The SCOT (Scleroderma: Cyclophosphamide Or Transplantation) Trial

M. Mayes, W. Clair, K. Sullivan, 2010 .

Epidemiology of acute myeloid leukemia in Virginia: Excellent survival outcomes for patients in rural Appalachia

R. Balkrishnan, K. Ballen, E. Williams, 2021, Cancer reports.

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

J. Klein, K. Ballen, Stephanie J. Lee, 2007 .

Health care utilization and end‐of‐life care for older patients with acute myeloid leukemia

J. Temel, T. Graubert, K. Ballen, 2015, Cancer.

Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population‐based study

D. Neuberg, K. Ballen, A. Fathi, 2017, Cancer.

A Phase I Study of the Multi-Targeted Tyrosine Kinase Inhibitor Cabozantinib in Patients with Acute Myeloid Leukemia

D. Neuberg, K. Ballen, M. Levis, 2016 .

Umbilical Cord Blood Transplantation

K. Ballen, M. Delaney, 2015, Journal of intensive care medicine.

Barriers to Access to Hematopoietic Cell Transplantation among Patients with Acute Myeloid Leukemia in Virginia.

R. Balkrishnan, K. Ballen, S. Devine, 2021, Transplantation and cellular therapy.

FT1050 (16,16-dimethyl Prostaglandin E2)-Enhanced Umbilical Cord Blood Accelerates Hematopoietic Engraftment After Reduced Intensity Conditioning and Double Umbilical Cord Blood Transplantation

W. Goessling, C. Desponts, J. Ritz, 2011 .

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8+T Cells.

J. Ritz, K. Stevenson, K. Ballen, 2007 .

A Phase I Study of the Aurora a Kinase Inhibitor Alisertib in Combination with 7+3 Induction Chemotherapy in Patients with Acute Myeloid Leukemia

D. Neuberg, T. Graubert, K. Ballen, 2014 .

Parathyroid Hormone May Improve Autologous Stem Cell Mobilization Via the Stem Cell Niche.

B. Yeap, E. Shpall, K. Ballen, 2005 .

Harvesting Hematopoietic Progenitors : “ Please Release Me , Let Me Go ”

K. Ballen, P. McCarthy, P. Mcsweeney, 2022 .

Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.

L. Zon, W. Goessling, C. Desponts, 2013, Blood.

Contained rupture of the inferior vena cava: diagnosis by ultrasonography and magnetic resonance imaging

K. Ballen, D. Brown, S. Mukherji, 1992, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations

P. Piccaluga, K. Ballen, D. DeAngelo, 2010, American journal of hematology.

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

J. Wingard, K. Ballen, Y. Nieto, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia

D. Neuberg, D. Zahrieh, K. Ballen, 2008, Clinical Cancer Research.

Cardiac Transplantation Followed by Dose-Intensive Melphalan and Autologous Stem-Cell Transplantation for Light Chain Amyloidosis and Heart Failure

M. Skinner, D. Seldin, K. Ballen, 2010, Transplantation.

Health care utilization and end‐of‐life care for older patients with acute myeloid leukemia

J. Temel, T. Graubert, K. Ballen, 2015, Cancer.

Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant.

K. Ballen, Yi-Bin Chen, T. Spitzer, 2012, Blood.

Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy.

W. Levy, P. Quesenberry, T. Fitzgerald, 2002, Blood.

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

S. Solomon, D. Blaise, A. Nagler, 2019, Bone Marrow Transplantation.

Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.

J. Ritz, K. Stevenson, P. Armand, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.

Maria E. Kempner, P. Oefner, Y. Taur, 2018, Blood Advances.

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults

M. Pasquini, K. Ballen, J. Liesveld, 2008 .

The expanding frontier of hematopoietic cell transplantation

K. Ballen, Yi-Bin Chen, T. Spitzer, 2012, Cytometry. Part B, Clinical cytometry.

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

P. Armand, K. Ballen, R. Soiffer, 2007 .

Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis.

J. Ritz, K. Stevenson, P. Armand, 2010, Blood.